上海医药集团股份有限公司2025年半年度权益分派实施公告

Core Viewpoint - Shanghai Pharmaceuticals Group Co., Ltd. announced a cash dividend distribution of 0.12 RMB per share for the first half of 2025, approved at the second extraordinary general meeting of shareholders on December 9, 2025 [2][3]. Distribution Plan - The distribution is based on a total share capital of 3,708,361,809 shares, with A-shares accounting for 2,789,289,105 shares, resulting in a total cash dividend payout of approximately 445 million RMB, of which about 335 million RMB is allocated to A-share dividends [4]. - The cash dividend will be distributed to all A-share shareholders registered with China Securities Depository and Clearing Corporation Limited, Shanghai Branch, as of the close of trading on the day before the dividend record date [3][4]. Implementation Details - The cash dividends for A-shares will be distributed through the clearing system of China Securities Depository and Clearing Corporation Limited, with shareholders who have designated trading able to receive their dividends on the payment date [5]. - For shareholders without designated trading, the dividends will be held by China Securities Depository and Clearing Corporation Limited until they complete the necessary trading arrangements [5]. Taxation Information - For individual shareholders holding unrestricted A-shares, the tax treatment varies based on the holding period, with a maximum tax rate of 20% for shares held for one month or less, and a reduced rate of 10% for shares held between one month and one year [9]. - For institutional investors classified as resident enterprises under the Corporate Income Tax Law, they are responsible for their own tax payments, with the actual cash dividend remaining at 0.12 RMB per share [10]. - Qualified Foreign Institutional Investors (QFIIs) will have a withholding tax of 10% applied to their dividends, with provisions for tax treaty benefits available [11].